BACKGROUND: Cognitive impairment and dementia has been reported in autosomal dominant hereditary spastic paraparesis (HSP) linked to the SPG4 locus. There has only been one postmortem examination described; not all accept that progressive cognitive decline is a feature of this disorder. OBJECTIVE: A family with SPG4-HSP known to have a deletion of exon 17 in the spastin gene (SPG4delEx17) was cognitively assessed over a 7-year period. The index family member died and a postmortem examination was performed. METHODS: Thirteen family members older than 40 years were clinically and cognitively assessed using the Cambridge Cognitive Assessment over a 7-year period. The presence of SPG4delEx17 was assessed; a neuropathologic examination of the brain of the index family member was performed. RESULTS: Cognitive decline occurred in 6 of the 13 family members and in all 4 older than 60 years. Two genetic deletions were identified: SPG4delEx17 in 12 of the 13 family members and a deletion of SPG6 (SPG6del) in 5. Eight individuals had the SPG4delEx17 deletion only; 4 had evidence of progressive cognitive impairment. Four family members had both SPG4delEx17 and SPG6del; 2 of these had cognitive impairment. One family member with the SPG6del alone had neither HSP nor cognitive impairment. The index case with both deletions died with dementia; the brain showed widespread ubiquitin positivity within the neocortex and white matter. CONCLUSION: Cognitive decline and dementia is a feature of SPG4-HSP due to a deletion of exon 17 of the spastin gene.
BACKGROUND:Cognitive impairment and dementia has been reported in autosomal dominant hereditary spastic paraparesis (HSP) linked to the SPG4 locus. There has only been one postmortem examination described; not all accept that progressive cognitive decline is a feature of this disorder. OBJECTIVE: A family with SPG4-HSP known to have a deletion of exon 17 in the spastin gene (SPG4delEx17) was cognitively assessed over a 7-year period. The index family member died and a postmortem examination was performed. METHODS: Thirteen family members older than 40 years were clinically and cognitively assessed using the Cambridge Cognitive Assessment over a 7-year period. The presence of SPG4delEx17 was assessed; a neuropathologic examination of the brain of the index family member was performed. RESULTS:Cognitive decline occurred in 6 of the 13 family members and in all 4 older than 60 years. Two genetic deletions were identified: SPG4delEx17 in 12 of the 13 family members and a deletion of SPG6 (SPG6del) in 5. Eight individuals had the SPG4delEx17 deletion only; 4 had evidence of progressive cognitive impairment. Four family members had both SPG4delEx17 and SPG6del; 2 of these had cognitive impairment. One family member with the SPG6del alone had neither HSP nor cognitive impairment. The index case with both deletions died with dementia; the brain showed widespread ubiquitin positivity within the neocortex and white matter. CONCLUSION:Cognitive decline and dementia is a feature of SPG4-HSP due to a deletion of exon 17 of the spastin gene.
Authors: Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski Journal: Am J Hum Genet Date: 2014-07-24 Impact factor: 11.025
Authors: Philip M Boone; Pengfei Liu; Feng Zhang; Claudia M B Carvalho; Charles F Towne; Sat Dev Batish; James R Lupski Journal: Genet Med Date: 2011-06 Impact factor: 8.822
Authors: Grant Guthrie; Gerald Pfeffer; Maura Bailie; Karen Bradshaw; Andrew C Browning; Rita Horvath; Patrick F Chinnery; Patrick Yu-Wai-Man Journal: J Neurol Date: 2012-12-13 Impact factor: 4.849
Authors: Thiago J R Rezende; Milena de Albuquerque; Gustavo M Lamas; Alberto R M Martinez; Brunno M Campos; Raphael F Casseb; Cynthia B Silva; Lucas M T Branco; Anelyssa D'Abreu; Iscia Lopes-Cendes; Fernando Cendes; Marcondes C França Journal: PLoS One Date: 2015-02-06 Impact factor: 3.240
Authors: Krister W Fjermestad; Øivind J Kanavin; Eva E Næss; Lise B Hoxmark; Grete Hummelvoll Journal: Orphanet J Rare Dis Date: 2016-07-13 Impact factor: 4.123